Home LiteratureArticle Details
PMID: 12692228 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Genome delivery and ion channel properties are altered in VP4 mutants of poliovirus.

Journal of virology ·Vol. 77 ·No. 9 ·2003-05-00 ·Pages 5266-74

Danthi P, Tosteson M, Li QH, Chow M

Abstract

During entry into host cells, poliovirus undergoes a receptor-mediated conformational transition to form 135S particles with irreversible exposure of VP4 capsid sequences and VP1 N termini. To understand the role of VP4 during virus entry, the fate of VP4 during infection by site-specific mutants at threonine-28 of VP4 (4028T) was compared with that of the parental Mahoney type 1 virus. Three virus mutants were studied: the entry-defective, nonviable mutant 4028T.G and the viable mutants 4028T.S and 4028T.V, in which residue threonine-28 was changed to glycine, serine, and valine, respectively. We show that mutant and wild-type (WT) VP4 proteins are localized to cellular membranes after the 135S conformational transition. Both WT and viable 4028T mutant particles interact with lipid bilayers to form ion channels, whereas the entry-defective 4028T.G particles do not. In addition, the electrical properties of the channels induced by the mutant viruses are different from each other and from those of WT Mahoney and Sabin type 3 viruses. Finally, uncoating and/or cytoplasmic delivery of the viral genome is altered in the 4028T mutants: the 4028T.G lethal mutant does not release its genome into the cytoplasm, and genome delivery is slower during infection by mutant 4028T.V 135S particles than by mutant 4028T.S or WT 135S particles. The distinctive electrical characteristics of the different 4028T mutant channels indicate that VP4 sequences might form part of the channel structure. The different entry phenotypes of these VP4 mutants suggest that the ion channels may be related to VP4's role during genome uncoating and/or delivery.

MeSH Terms
Capsid Proteins/chemistry,genetics,metabolism Cell Membrane/metabolism Genome, Viral HeLa Cells Humans Ion Channels/metabolism Mutation Poliovirus/genetics,pathogenicity RNA, Viral/metabolism Virion/metabolism Virus Assembly
Chemicals
Capsid Proteins Ion Channels RNA, Viral
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Danthi Pranav
Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock 72205, USA.
Tosteson Magdalena
Li Qi-Han
Chow Marie
References (29)
29 references, click to expand
  1. Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirus.
    J Virol. 2000 Feb;74(3):1342-54 PMID: 10627545
  2. ASPECTS OF THE GROWTH OF POLIOVIRUS AS REVEALED BY THE PHOTODYNAMIC EFFECTS OF NEUTRAL RED AND ACRIDINE ORANGE.
    Virology. 1963 Oct;21:135-45 PMID: 14070166
  3. Stabilization of poliovirus by capsid-binding antiviral drugs is due to entropic effects.
    J Mol Biol. 2000 Feb 18;296(2):335-40 PMID: 10669591
  4. Is the 135S poliovirus particle an intermediate during cell entry?
    J Virol. 2000 Sep;74(18):8757-61 PMID: 10954579
  5. Studies on the in vitro uncoating of poliovirus. II. Characteristics of the membrane-modified particle.
    Virology. 1977 May 15;78(2):554-66 PMID: 194397
  6. Three-dimensional structure of poliovirus at 2.9 A resolution.
    Science. 1985 Sep 27;229(4720):1358-65 PMID: 2994218
  7. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
    Proc Natl Acad Sci U S A. 1986 Nov;83(21):8122-6 PMID: 3095828
  8. Myristylation of picornavirus capsid protein VP4 and its structural significance.
    Nature. 1987 Jun 11-17;327(6122):482-6 PMID: 3035380
  9. Role of 3'-end sequences in infectivity of poliovirus transcripts made in vitro.
    J Virol. 1989 Jan;63(1):467-70 PMID: 2535751
  10. Mutations in VP1 of poliovirus specifically affect both encapsidation and release of viral RNA.
    J Virol. 1990 Jan;64(1):195-206 PMID: 2152812
  11. Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding.
    J Virol. 1990 May;64(5):1934-45 PMID: 2157861
  12. Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity.
    J Virol. 1990 May;64(5):2433-6 PMID: 2157900
  13. Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles.
    J Virol. 1990 Sep;64(9):4099-107 PMID: 2166807
  14. Myristoylation is important at multiple stages in poliovirus assembly.
    J Virol. 1991 May;65(5):2372-80 PMID: 1850017
  15. Influence of different ionic and pH environments on structural alterations of poliovirus and their possible relation to virus uncoating.
    J Gen Virol. 1991 Oct;72 ( Pt 10):2541-4 PMID: 1655960
  16. Ion channels in icosahedral virus: a comparative analysis of the structures and binding sites at their fivefold axes.
    Biophys J. 1992 Oct;63(4):1133-45 PMID: 1384743
  17. Myristate-protein interactions in poliovirus: interactions of VP4 threonine 28 contribute to the structural conformation of assembly intermediates and the stability of assembled virions.
    J Virol. 1992 Dec;66(12):6849-57 PMID: 1331497
  18. Efficient analysis of nonviable poliovirus capsid mutants.
    J Virol. 1993 Mar;67(3):1734-8 PMID: 8382319
  19. A mutation in VP4 defines a new step in the late stages of cell entry by poliovirus.
    J Virol. 1993 Aug;67(8):5075-8 PMID: 8392631
  20. Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature.
    J Virol. 1994 Jun;68(6):3965-70 PMID: 7514682
  21. Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 A resolution.
    Protein Sci. 1994 Oct;3(10):1651-69 PMID: 7849583
  22. Reverse transcription multiplex PCR for differentiation between polio- and enteroviruses from clinical and environmental samples.
    J Clin Microbiol. 1995 Jun;33(6):1442-7 PMID: 7650164
  23. Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating.
    J Virol. 1996 Jan;70(1):305-12 PMID: 8523541
  24. The poliovirus 135S particle is infectious.
    J Virol. 1996 Oct;70(10):7125-31 PMID: 8794359
  25. Characterization of the ion channels formed by poliovirus in planar lipid membranes.
    J Virol. 1997 Jan;71(1):507-11 PMID: 8985378
  26. Inhibition of host cell transcription by poliovirus: cleavage of transcription factor CREB by poliovirus-encoded protease 3Cpro.
    J Virol. 1997 Feb;71(2):1220-6 PMID: 8995645
  27. Cleavage of transcriptional activator Oct-1 by poliovirus encoded protease 3Cpro.
    Virology. 1997 Dec 8;239(1):176-85 PMID: 9426457
  28. The incorporation of neutral red and acridine orange into developing poliovirus particles making them photosensitive.
    Virology. 1961 May;14:11-21 PMID: 13696675
  29. The amino-terminal nine amino acid sequence of poliovirus capsid VP4 protein is sufficient to confer N-myristoylation and targeting to detergent-insoluble membranes.
    Biochemistry. 2000 Feb 8;39(5):1083-90 PMID: 10653654
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2003-05-00
Pages
5266-74
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC153979
Subset
IM
Grants
NIAID NIH HHS · R01 AI042390 · United States
NIAID NIH HHS · AI42390 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com